Stock listing
CSE:AIML AIML Innovations Inc Stock
Home listing (CSE) of AIML Innovations Inc
Follow AIML Innovations Inc into a list and get an email when it puts out news.
Share price · CSE:AIML
$0.045 CAD 0.000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.045 – $0.045 CADNov 20, 2026
- Volume
- 71,250 sharesNov 20, 2026
- Market cap
- $13.88M CADAt the close on Nov 20, 2026 · price × 308.4M shares outstanding
- 52-week range
- $0.030 – $0.085 CADLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $8,462 CADMedian day 85,479 shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:AIML · Home | $0.045 CAD | 0.000 (0.0%) | 71,250 | $0.045 | $0.045 | $0.045 | $0.045 | Close on Nov 20, 2026 |
| OTC:AIMLF | $0.029 USD | -0.001 (-3.3%) | 5,453 | $0.029 | $0.029 | $0.029 | $0.030 | Close on Nov 20, 2026 |
| Frankfurt:42FB | €0.025 EUR | 0.000 (0.0%) | — | €0.025 | €0.025 | €0.025 | €0.025 | Close on Nov 20, 2026 |
| Dusseldorf:42FB | €0.024 EUR | 0.000 (0.0%) | — | €0.024 | €0.024 | €0.024 | €0.024 | Close on Nov 20, 2026 |
| Munich:42FB | €0.028 EUR | 0.000 (0.0%) | 8,000 | €0.028 | €0.028 | €0.028 | €0.028 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · CSE:AIML · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 71,250 | |
| $0.045 | 0.000 | 0.0% | $0.040 | $0.050 | $0.040 | 159,571 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.050 | $0.045 | 79,502 | |
| $0.045 | 0.000 | 0.0% | $0.050 | $0.050 | $0.045 | 382,001 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.050 | $0.045 | 200,190 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 15,000 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 194,212 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.045 | $0.040 | 566,101 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 223,000 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 60,000 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 691,765 | |
| $0.045 | -0.005 | -10.0% | $0.040 | $0.045 | $0.040 | 70,597 | |
| $0.050 | +0.005 | +11.1% | $0.045 | $0.050 | $0.045 | 20,000 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | +0.005 | +12.5% | $0.040 | $0.045 | $0.040 | 395,345 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 55,200 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 104,750 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 825,387 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 58,493 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 76,212 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 2,016 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.045 | $0.045 | 3,000 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 68,008 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 1,812 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 19,222 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 184,666 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 182,000 | |
| $0.045 | -0.005 | -10.0% | $0.050 | $0.050 | $0.045 | 247,317 | |
| $0.050 | +0.005 | +11.1% | $0.050 | $0.050 | $0.050 | 658,227 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.045 | 18,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 50,688 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 157,004 | |
| $0.050 | 0.000 | 0.0% | $0.045 | $0.050 | $0.045 | 461,539 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.045 | 129,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 142,000 | |
| $0.050 | +0.005 | +11.1% | $0.050 | $0.050 | $0.050 | 10,499 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 430,000 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 27,890 | |
| $0.045 | +0.005 | +12.5% | $0.040 | $0.045 | $0.040 | 124,900 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 150,850 | |
| $0.045 | +0.005 | +12.5% | $0.040 | $0.045 | $0.040 | 91,455 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 25,000 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 102,979 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 13,000 | |
| $0.040 | 0.000 | 0.0% | $0.035 | $0.040 | $0.035 | 2,000 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 745,676 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 119,849 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 14,253 | |
| $0.040 | 0.000 | 0.0% | $0.040 | $0.040 | $0.040 | 107,500 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 1,803,450 | |
| $0.045 | 0.000 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.045 | $0.045 | 100,000 | |
| $0.040 | -0.005 | -11.1% | $0.040 | $0.040 | $0.040 | 108,830 | |
| $0.045 | -0.005 | -10.0% | $0.050 | $0.050 | $0.040 | 999,243 | |
| $0.050 | 0.000 | 0.0% | $0.045 | $0.050 | $0.045 | 197,999 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 20,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 582,130 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 2,000 | |
| $0.050 | 0.000 | 0.0% | $0.050 | $0.050 | $0.050 | 0 |
Splits
3 splits since 2009 · CSE:AIML · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation | |
| 2-for-1 | Split | |
| 1-for-5 | Consolidation |
- Ticker
- CSE:AIML
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- CSE
- Currency
- CAD
What changed lately
Latest news release · Nov 17, 2026
AI/ML Innovations Inc. Closes First Tranche of Private Placement
Latest deck · Dec 18, 2025
Investor Presentation (December 2025)
Investor deck · 39 slides
Latest news
AI/ML Innovations Inc. Closes First Tranche of Private Placement
Nov 17, 2026
Closed $0.045 (0.0%) on Nov 18, 2026
AIML Subsidiary NeuralCloud Signs Agreement With MyCor360+ to Integrate MaxYield(TM) into Next-Generation Cardiac Monitoring Device
Nov 12, 2026
Closed $0.04 (-11.1%) on Nov 12, 2026
AI/ML Innovations Inc. Announces Proposed Private Placement
Nov 5, 2026
Closed $0.04 (-11.1%) on Nov 5, 2026
AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield(TM)
Oct 29, 2026
Closed $0.04 (0.0%) on Oct 29, 2026
AI/ML Innovations Announces Advance Notice Provisions
Oct 28, 2026
Closed $0.04 (0.0%) on Oct 28, 2026
AI/ML Innovations Announces Completion of Share Issuance
Oct 13, 2026
Closed $0.045 (0.0%) on Oct 14, 2026
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Oct 2, 2026
Closed $0.05 (+11.1%) on Oct 2, 2026
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services
Oct 1, 2026
Closed $0.045 (-10.0%) on Oct 1, 2026
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield(TM) Clinical Pilots
Sep 29, 2026
Closed $0.05 (0.0%) on Sep 29, 2026
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
Sep 21, 2026
Closed $0.045 (0.0%) on Sep 21, 2026
AIML Innovations Inc on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 37 in the last 12 months · 105 in all · newest Nov 17, 2026 · oldest 2005
- Decks
- 1 deck · latest Dec 18, 2025
Where AIML Innovations Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:AIML · Home listing · This page | CSE | Canada | CAD |
| Cboe Canada:AIML | Cboe Canada | Canada | CAD |
| OTC:AIMLF | OTC | United States | USD |
| Tradegate:42FB | Tradegate | Germany | EUR |
| gettex:42FB | gettex | Germany | EUR |
| LS Exchange:A2QMBE | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2QMBE | Lang & Schwarz | Germany | EUR |
| Frankfurt:42FB | Frankfurt | Germany | EUR |
| Dusseldorf:42FB | Dusseldorf | Germany | EUR |
| Hamburg:42FB | Hamburg | Germany | EUR |
| Munich:42FB | Munich | Germany | EUR |
| Stuttgart:42FB | Stuttgart | Germany | EUR |
Valuation
EV/sales 369× against a median of 2.0×: 9th lowest of 10 Health care services companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026
- Enterprise value
- $16.10M CAD
- P/E
- Loss
- EV/sales
- 369×
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- 97.8%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- Negative equity
- Beta vs S&P/TSX Composite
- 0.33
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| AIML Innovations Inc · CSE:AIML | US$9.68M | US$11.23M | n/a | 369× | n/a | n/a | n/a | n/a | 0.33 |
| Republic Healthcare Limited · HKEX:8357 | US$10.83M | US$9.29M | n/a | 1.2× | n/a | 1.8× | −40.3% | 0.4× | n/a |
| Scandinavian Medical Solutions A/S · OMXCOP:SMSMED | US$10.61M | US$21.25M | 2,780× | 0.6× | 13.9× | 1.0× | 0.0% | 1.0× | n/a |
| Medilines Distributors, Inc. · PSE:MEDIC | US$10.33M | US$9.37M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | n/a |
| KT Medical Service Public Company Limited · SET:KTMS | US$10.25M | US$8.24M | 9.6× | 0.4× | 2.8× | 0.6× | 5.1% | 0.0× | n/a |
| Morefield Group N.V. · EURONEXT:MORE | US$10.12M | US$75.51M | 2.2× | 0.4× | 2.6× | 0.4× | 2.6% | 3.1× | n/a |
| Concord Medical Services Holdings Ltd. · NYSE:CCM | US$9.99M | US$509.8M | n/a | 7.4× | n/a | n/a | −20.2% | n/a | 0.49 |
| Vidavo SA · ATHEX:VIDAVO | US$9.78M | US$8.25M | 15.0× | 3.5× | 9.2× | 4.1× | 27.4% | 0.0× | n/a |
| UCrest Bhd · MYX:UCREST | US$9.05M | US$6.78M | 138× | 2.0× | 34.7× | 0.9× | 1.9% | 0.0× | n/a |
| HeartSciences Inc. · NASDAQ:HSCS | US$8.99M | US$8.96M | n/a | 1,984× | n/a | n/a | n/a | n/a | 1.23 |
| PainChek Ltd · ASX:PCK | US$8.86M | US$7.71M | n/a | 3.1× | n/a | n/a | −238.8% | n/a | n/a |
| Median of the others | US$10.06M | US$9.13M | 15.0× | 2.0× | 9.2× | 0.9× | 1.0% | 0.0× | 0.86 |
Team and board
Officers
| Officer | Role |
|---|---|
| Paul Duffy | Executive Chairman & CEO |
| Lynn Chapman | CFO, AIML |
| Esmat Naikyar | CPO · President, Neural Cloud |
| Erik Suokas | COO, AIML & Neural Cloud |
| Alan Rabinowitz | Chief Medical Officer |
| Mehmet A. Kosoglu | Head of Regulatory for NeuralCloud Solutions Inc. |
| Paul Dorian | Medical Innovation Architect and Head of the Medical Advisory Board |
Board
| Director | Role |
|---|---|
| Paul Duffy | Executive Chairman & CEO |
| Jared Adelstein | Independent Director |
| Michael Diamond | Independent Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2025) | Investor deck | 39 slides | Dec 18, 2025 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of units Tranche closed: C$500,000 raised · C$0.05 a unit · 1 warrant at C$0.15 for 60 months · free to trade Mar 18, 2027 Use of proceeds: General working capital | Nov 17, 2026 | US$349,871 |
| Private placement of units Closed: C$365,000 in the latest tranche · C$0.05 a unit · 1 warrant at C$0.15 for 60 months · free to trade Jan 15, 2027 | Sep 14, 2026 | |
| Private placement of units Closed: C$2.13M raised · C$0.05 a unit · 1 warrant at C$0.15 for 60 months · free to trade Jan 23, 2026 Buyers: Paul Duffy (5,000,000 Units through a company he owns and controls); Peter Kendall (500,000 Units through a company he owns and controls); Esmatullah Naikyar (120,000 Units); Sheldon Inwentash (26,000,000 Units (6,000,000 to ThreeD Capital Inc and 20,000,000 to Park Place Limited)) Insiders: CEO Paul Duffy 5,000,000 Units, President Peter Kendall 500,000 Units, CPO Esmatullah Naikyar 120,000 Units and 10% shareholder Sheldon Inwentash 26,000,000 Units; related party transaction under MI 61-101 Use of proceeds: General working capital | Sep 23, 2025 | US$1.54M |
| Private placement of units Terms changed: up to C$2M · C$0.05 a unit · 1 warrant at C$0.15 for 36 months Use of proceeds: Working capital requirements | Apr 7, 2025 | US$1.41M |
| Private placement of units Closed: C$2.87M raised · C$0.065 a unit · 1 warrant at C$0.15 for 24 months · free to trade Mar 27, 2025 Insiders: Three insiders subscribed for 6,650,000, representing 27.14% of the Units issued on this closing Use of proceeds: Working capital requirements | Nov 26, 2024 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in CAD
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 83.1K | 167.3K | 600.1K | 487.5K | 65.4K | 0 | 0 | 0 | 0 | |
| Cost of revenue | 1.94K | 4.50K | 305.3K | 21.5K | 0 | |||||
| Gross profit | 81.1K | 162.8K | 294.9K | 466.0K | 65.4K | |||||
| Research and development | 1.01M | 388.0K | 172.4K | 163.0K | 391.8K | 93.9K | 0 | |||
| Selling, general and administrative | 5.27M | 4.50M | 1.71M | 1.45M | 2.99M | 1.37M | 176.5K | 98.5K | 96.5K | 118.0K |
| Operating income | -6.49M | -4.84M | -1.62M | -1.35M | -3.35M | -1.43M | -176.5K | -98.5K | -96.5K | -118.0K |
| Depreciation and amortization | 95.2K | 25.9K | 42.1K | 42.1K | 42.1K | 168.4K | 3.02K | 3.02K | 3.02K | 125.4K |
| EBITDA | -6.39M | -4.81M | -1.58M | -1.30M | -3.31M | -1.26M | -173.5K | -95.5K | -93.5K | 7.46K |
| Interest expense | 47.0K | 23.4K | 52.0K | 58.5K | 65.9K | 41.5K | 39.0K | 37.2K | 0 | 0 |
| Income before tax | -6.36M | -4.59M | -3.29M | -1.49M | -3.55M | -2.83M | -215.5K | -166.7K | -124.1K | 88.1K |
| Net income | -6.36M | -4.59M | -3.28M | -1.42M | -3.17M | -2.73M | -215.5K | -166.7K | -124.1K | 88.1K |
| Earnings per share, basic | -0.02 | -0.02 | -0.04 | -0.03 | -0.09 | -0.09 | -0.02 | -0.02 | -0.02 | 0.01 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 251.3K | 1.99M | 201.5K | 4.53K | 475.1K | 3.37M | 137.8K | 3.81K | 30.9K | 36.8K |
| Short-term investments | 6.45K | 6.45K | 15.4K | 10.0K | 50.2K | 118.3K | 39.4K | 17.9K | 50.2K | 43.0K |
| Receivables | 0 | 13.8K | 21.1K | 115.1K | 24.8K | 34.8K | 1.94K | 18.9K | 19.2K | 16.3K |
| Inventory | 0 | 2.85K | 2.85K | 3.32K | 4.68K | 1.75K | ||||
| Current assets | 1.52M | 2.45M | 329.7K | 227.4K | 895.2K | 3.59M | 179.1K | 40.7K | 100.3K | 96.2K |
| Property, plant and equipment | 42.1K | 84.1K | 140.8K | 116.0K | 61.0K | 42.2K | ||||
| Total assets | 2.07M | 3.41M | 329.7K | 1.51M | 2.04M | 3.59M | 319.9K | 156.6K | 161.3K | 138.4K |
| Accounts payable | 670.6K | 314.9K | 368.4K | 563.0K | 349.9K | 315.7K | 636.8K | 671.8K | 659.0K | 681.9K |
| Current liabilities | 2.08M | 819.3K | 1.54M | 1.79M | 1.46M | 1.47M | 2.14M | 2.09M | 1.93M | 1.78M |
| Long-term debt | 808.7K | 40.0K | 40.0K | |||||||
| Total liabilities | 2.89M | 855.8K | 1.54M | 1.79M | 1.55M | 1.51M | 2.14M | 2.09M | 1.93M | 1.78M |
| Shareholders' equity | -785.2K | 2.60M | -1.17M | -247.5K | 1.08M | 2.31M | -1.82M | -1.93M | -1.77M | -1.64M |
| Shares outstanding | 271.1M | 216.7M | 77.4M | 44.2M | 34.9M | 29.1M | 11.1M | 8.10M | 8.10M | 8.10M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.41M | -3.99M | -1.64M | -634.3K | -3.02M | -931.3K | -126.9K | -7.15K | -37.1K | -22.0K |
| Capital spending | -4.67K | -1.15K | 0 | 0 | 0 | -27.7K | -27.8K | -19.9K | -18.8K | -14.4K |
| Free cash flow | -5.41M | -3.99M | -1.64M | -648.1K | -3.02M | -931.3K | -126.9K | -7.15K | -37.1K | -36.4K |
| Cash from investing | -210.6K | -1.09M | -11.4K | -27.8K | -19.9K | -18.8K | 57.3K | |||
| Cash from financing | 3.67M | 5.78M | 2.16M | 374.4K | 1.22M | 4.17M | 288.6K | 288.6K | 50.0K | 50.0K |
| Dividends paid | 0 | 0 | 0 | |||||||
| Change in cash | -1.74M | 1.79M | 196.9K | -470.5K | -2.89M | 3.23M | 133.9K | -27.1K | -5.93K | 35.3K |
Cap table
Built by 6ix from AIML Innovations Inc’s releases · as of Nov 17, 2026
- Common shares
- 308,351,507
- Fully diluted
- 394,136,972
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 308,351,507 | Nov 17, 2026 |
| Warrants | 85,785,465 | Nov 17, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · C$0.15 · expire about Nov 2031 |
| Broker warrants · C$0.15 · expire about Sep 2031 |
| Warrants · C$0.15 · expire about Aug 2031 |
| Warrants · C$0.15 · expire about Sep 2030 |
| Warrants · C$0.15 · expire about Nov 2026 |
| Broker warrants · C$0.15 · expiry not stated |
| Broker warrants · C$0.15 · expiry not stated |
| Broker warrants · C$0.15 · expiry not stated |
Share count over time
| Count | Shares |
|---|---|
| Nov 17, 2026 | 308,351,507 |
| Sep 14, 2026 | 298,351,507 |
| Aug 26, 2026 | 291,051,507 |
| Jul 31, 2026 | 274,666,507 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alan Rabinowitz Other companies: AI/ML Innovations Inc (Chief Medical Officer and Director of Medical Partnerships · Since Jan 27, 2025 · Appointed, no departure found) | Chief Medical Officer · Since at least Jan 27, 2025 |
| Erik Suokas Other companies: AI/ML Innovations Inc (Chief Operating Officer · Since Jan 7, 2026 · Appointed, no departure found) | COO, AIML & Neural Cloud · Since at least Jan 7, 2026 |
| Kendra Low Other companies: AI/ML Innovations Inc (Corporate Secretary · Since Dec 3, 2024 · Appointed, no departure found) | Corporate Secretary · Dec 3, 2024 – Nov 4, 2026 · Past |
| Lynn Chapman Other companies: AI/ML Innovations Inc (Chief Financial Officer · Since Oct 1, 2026 · Appointed, no departure found) | CFO, AIML · Since Oct 1, 2026 |
| Mehmet A. Kosoglu Other companies: AI/ML Innovations Inc (Head of Regulatory · Since Sep 1, 2026 · Appointed, no departure found) | Head of Regulatory for NeuralCloud Solutions Inc. · Since at least Sep 1, 2026 |
| Paul Dorian Other companies: AI/ML Innovations Inc (Medical Innovation Architect and Head of the Medical Advisory Board · Since Jan 28, 2026 · Appointed, no departure found) | Medical Innovation Architect and Head of the Medical Advisory Board · Since at least Jan 28, 2026 |
| Peter Kendall Other companies: AI/ML Innovations Inc (President and Chief Commercialization Officer · Since Jan 6, 2025 · Appointed, no departure found) | President and Chief Commercialization Officer · Jan 6, 2025 – Nov 4, 2026 · Past |
| Terence Lee Other companies: AI/ML Innovations Inc (Chief Financial Officer · Dec 3, 2024 – Oct 2, 2026 · Past) | Chief Financial Officer · Dec 3, 2024 – Nov 4, 2026 · Past |
| Andrea L. Ruth | Head of Quality, Clinical · Feb 5, 2025 – Nov 4, 2026 · Past |
| Drew Dundas | Chair · May 22, 2025 – Nov 4, 2026 · Past |
All 15 people
| Person | Seat |
|---|---|
| Esmat Naikyar | CPO · President, Neural Cloud · Since at least Oct 29, 2026 |
| Jared Adelstein | Independent Director · Since at least Apr 22, 2025 |
| Michael Diamond | Independent Director · Since at least May 5, 2025 |
| Paul Duffy | Executive Chairman & CEO · Since at least Oct 29, 2026 |
| Tim Daniels | Director · Jan 9, 2025 – Nov 4, 2026 · Past |
Log in to ask 6ix AI your own questions about AIML Innovations Inc.